• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

竞争性健康保险市场中的风险均衡:基于多年低支出识别健康个体。

Risk equalization in competitive health insurance markets: Identifying healthy individuals on the basis of multiple-year low spending.

机构信息

Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.

出版信息

Health Serv Res. 2019 Apr;54(2):455-465. doi: 10.1111/1475-6773.13065. Epub 2018 Oct 16.

DOI:10.1111/1475-6773.13065
PMID:30328096
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6407341/
Abstract

OBJECTIVE

To study the extent to which risk equalization (RE) in competitive health insurance markets can be improved by including an indicator for being healthy.

STUDY SETTING/DATA SOURCES: This study is conducted in the context of the Dutch individual health insurance market. Administrative data on spending and risk characteristics (2011-2014) for the entire population (N = 16.6 m) as well as health survey data from a large sample (N = 387 k) are used.

STUDY DESIGN

The indicator for being healthy is low spending in three consecutive prior years. "Low spending" is defined in three ways: belonging to the bottom 60%, 70%, or 80% of the annual spending distribution. Versions of the Dutch RE model 2017 with and without the indicator are compared on individual-level payment fit and, using the survey data, group-level payment fit.

PRINCIPAL FINDINGS

All three alternative models outperform the Dutch RE model 2017. However, significant unpriced risk heterogeneity remains. Compared with the 60% threshold, the 80% threshold comes with a larger improvement in fit but identifies a less selective group.

CONCLUSIONS

The performance of the RE model can be improved by adding an indicator for being healthy based on multiple-year low spending. However, risk-selection potential remains, warranting high priority to further improvement of RE.

摘要

目的

研究在竞争健康保险市场中,通过纳入健康指标,风险均等化(RE)可以在多大程度上得到改善。

研究背景/数据来源:本研究在荷兰个人健康保险市场的背景下进行。使用了关于整个人群(N=1660 万)支出和风险特征的管理数据(2011-2014 年),以及来自大样本(N=38.7 万)的健康调查数据。

研究设计

健康指标是连续三年的低支出。“低支出”以三种方式定义:属于年度支出分布的底部 60%、70%或 80%。比较了带有和不带有该指标的 2017 年荷兰 RE 模型在个体层面支付拟合度上的差异,并利用调查数据评估了群体层面支付拟合度。

主要发现

所有三种替代模型的表现均优于 2017 年荷兰 RE 模型。然而,仍存在显著的未定价风险异质性。与 60%的阈值相比,80%的阈值在拟合度方面有更大的提高,但确定了一个选择性较低的群体。

结论

通过基于多年低支出的健康指标,可以提高 RE 模型的性能。然而,风险选择的潜力仍然存在,因此需要高度优先考虑进一步改进 RE。

相似文献

1
Risk equalization in competitive health insurance markets: Identifying healthy individuals on the basis of multiple-year low spending.竞争性健康保险市场中的风险均衡:基于多年低支出识别健康个体。
Health Serv Res. 2019 Apr;54(2):455-465. doi: 10.1111/1475-6773.13065. Epub 2018 Oct 16.
2
Examining unpriced risk heterogeneity in the Dutch health insurance market.考察荷兰健康保险市场中未定价风险的异质性。
Eur J Health Econ. 2018 Dec;19(9):1351-1363. doi: 10.1007/s10198-018-0979-x. Epub 2018 Apr 18.
3
Selection Incentives in the Dutch Basic Health Insurance: To What Extent Does End-of-Life Spending Contribute to Predictable Profits and Losses for Selective Groups?荷兰基本健康保险中的选择激励:临终支出在多大程度上为选择性群体的可预测盈亏做出贡献?
Med Care Res Rev. 2022 Dec;79(6):819-833. doi: 10.1177/10775587221099731. Epub 2022 Jun 8.
4
Re-insurance in the Swiss health insurance market: Fit, power, and balance.瑞士健康保险市场中的再保险:适应性、影响力与平衡
Health Policy. 2016 Jul;120(7):848-55. doi: 10.1016/j.healthpol.2016.04.016. Epub 2016 Apr 30.
5
Improving risk equalization for individuals with persistently high costs: Experiences from the Netherlands.提高持续高额费用个体的风险均衡:荷兰的经验。
Health Policy. 2017 Nov;121(11):1169-1176. doi: 10.1016/j.healthpol.2017.09.007. Epub 2017 Sep 14.
6
Diagnosis-based Cost Groups in the Dutch Risk-equalization Model: Effects of Clustering Diagnoses and of Allowing Patients to be Classified into Multiple Risk-classes.荷兰风险均等化模型中基于诊断的成本组:诊断聚类以及允许患者被归入多个风险类别的影响
Med Care. 2018 Jan;56(1):91-96. doi: 10.1097/MLR.0000000000000828.
7
Improving risk equalization using multiple-year high cost as a health indicator.利用多年高额费用作为健康指标来改善风险均衡。
Med Care. 2012 Feb;50(2):140-4. doi: 10.1097/MLR.0b013e31822ebf8b.
8
Diagnostic, pharmacy-based, and self-reported health measures in risk equalization models.诊断、药学和自我报告的健康措施在风险均衡模型中。
Med Care. 2010 May;48(5):448-57. doi: 10.1097/MLR.0b013e3181d559b4.
9
Incorporating self-reported health measures in risk equalization through constrained regression.通过约束回归将自我报告的健康措施纳入风险均等化。
Eur J Health Econ. 2020 Jun;21(4):513-528. doi: 10.1007/s10198-019-01146-y. Epub 2020 Jan 8.
10
Predictable profits and losses in a health insurance market with risk equalization: A multiple-contract period perspective.风险均等化下健康保险市场中可预测的利润与损失:多合同期视角
Health Policy. 2023 May;131:104763. doi: 10.1016/j.healthpol.2023.104763. Epub 2023 Mar 8.

引用本文的文献

1
Risk Adjustment in Health Insurance Markets: Do Not Overlook the "Real" Healthy.健康保险市场中的风险调整:勿忽视“真正”的健康人群。
Med Care. 2024 Nov 1;62(11):767-772. doi: 10.1097/MLR.0000000000001955. Epub 2023 Dec 4.
2
How to deal with persistently low/high spenders in health plan payment systems?如何应对医保支付系统中持续的高/低费用支出者?
Health Econ. 2022 May;31(5):784-805. doi: 10.1002/hec.4477. Epub 2022 Feb 8.
3
Does the chronically ill population in the Netherlands switch their health insurer as often as the general population? Empirical evidence from a nationwide survey study.荷兰的慢性病患者是否像一般人群一样经常更换健康保险公司?一项全国性调查研究的实证证据。
BMC Health Serv Res. 2020 May 5;20(1):376. doi: 10.1186/s12913-020-05228-z.

本文引用的文献

1
Examining unpriced risk heterogeneity in the Dutch health insurance market.考察荷兰健康保险市场中未定价风险的异质性。
Eur J Health Econ. 2018 Dec;19(9):1351-1363. doi: 10.1007/s10198-018-0979-x. Epub 2018 Apr 18.
2
How Does Risk Selection Respond to Risk Adjustment? New Evidence from the Medicare Advantage Program.风险选择如何应对风险调整?来自医疗保险优势计划的新证据。
Am Econ Rev. 2014 Oct;104(10):3335-64. doi: 10.1257/aer.104.10.3335.
3
Measuring efficiency of health plan payment systems in managed competition health insurance markets.衡量管理竞争型医疗保险市场中健康计划支付系统的效率。
J Health Econ. 2017 Dec;56:237-255. doi: 10.1016/j.jhealeco.2017.05.004.
4
Diagnosis-based Cost Groups in the Dutch Risk-equalization Model: Effects of Clustering Diagnoses and of Allowing Patients to be Classified into Multiple Risk-classes.荷兰风险均等化模型中基于诊断的成本组:诊断聚类以及允许患者被归入多个风险类别的影响
Med Care. 2018 Jan;56(1):91-96. doi: 10.1097/MLR.0000000000000828.
5
Improving risk equalization using information on physiotherapy diagnoses.利用物理治疗诊断信息改进风险均衡
Eur J Health Econ. 2018 Mar;19(2):203-211. doi: 10.1007/s10198-017-0874-x. Epub 2017 Feb 9.
6
Improving risk equalization with constrained regression.用约束回归提高风险均衡性。
Eur J Health Econ. 2017 Dec;18(9):1137-1156. doi: 10.1007/s10198-016-0859-1. Epub 2016 Dec 10.
7
Tradeoffs in the design of health plan payment systems: Fit, power and balance.健康计划支付系统设计中的权衡:适配性、影响力与平衡性。
J Health Econ. 2016 May;47:1-19. doi: 10.1016/j.jhealeco.2016.01.007. Epub 2016 Feb 10.
8
High cost pool or high cost groups-How to handle high(est) cost cases in a risk adjustment mechanism?高成本池或高成本群体——如何在风险调整机制中处理最高成本病例?
Health Policy. 2016 Feb;120(2):141-7. doi: 10.1016/j.healthpol.2016.01.003. Epub 2016 Jan 12.
9
Risk Selection Threatens Quality Of Care For Certain Patients: Lessons From Europe's Health Insurance Exchanges.风险选择危及特定患者的医疗质量:来自欧洲医疗保险交易所的教训。
Health Aff (Millwood). 2015 Oct;34(10):1713-20. doi: 10.1377/hlthaff.2014.1456.
10
Overpaying morbidity adjusters in risk equalization models.在风险均等模型中过度支付发病率调整因子。
Eur J Health Econ. 2016 Sep;17(7):885-95. doi: 10.1007/s10198-015-0729-2. Epub 2015 Sep 29.